2026 Bioethics & Black History: The Legacy of the Tuskegee Report
Watch on YouTubeVideo summary
The 2026 Bioethics & Black History lecture at Harvard Medical School, hosted by Rebecca Brenell, critically examines the enduring legacy of the Tuskegee Syphilis Study and its impact on contemporary healthcare disparities. Although the study's exposure led to the Belmont Report in 1978, speakers argue that significant inequities persist, evidenced by a loss of approximately 80 million years of life for Black Americans between 1999 and 2020, alongside higher maternal and infant mortality rates. These outcomes are not accidental but stem from systemic vulnerabilities and co-morbidities like hypertension and diabetes that disproportionately affect Black communities, prompting a critique of the Belmont Report as a "Gordian knot" that focuses too narrowly on research ethics while neglecting broader social justice, autonomy, and care.
To address these deep-seated issues, the panel proposes the framework of "Black Bioethics," which is defined not by pigmentation but by a commitment to advocating for the least, lost, and left out. This approach shifts the focus from abstract principles to relational care, empathy, and community engagement, challenging the notion that technology and innovation are neutral forces. Instead, examples such as AI models trained on biased data, wearable devices designed for specific demographics while excluding those with diabetes-related amputations, and language tools that marginalize certain voices illustrate how current technologies often replicate existing biases rather than solving them. Consequently, ethical solutions require moving beyond top-down approaches to involve impacted communities in the design phase, lifting the veil of invisibility and reimagining bioethics through a lens of care, proximity, and global solidarity rather than Western hubris.
The discussion further explores the ethical implications of advanced technologies like prosthetics and xenotransplants, noting that while these innovations require significant funding often controlled by gaming companies, they must be partnered with communities to address healthcare disparities where Black and Brown populations face excess deaths and organ shortages. The speakers emphasize that technology amplifies structural inequalities unless guided by an ethics rooted in empathy, caring relationships, and community health models rather than isolated high-level technical expertise. This perspective encourages a collective approach to problem-solving, rejecting the burden of past failures and advocating for maintaining an "optimism of the will" over intellectual pessimism, thereby inspiring the next generation of bioethicists to imagine alternative futures without being constrained by historical limitations.
The event concludes with concrete plans for a future partnership between Harvard Medical School's Center for Bioethics and Tuskegee University's National Center for Bioethics and Research in Healthcare, marking a significant step toward collaborative action during Black History Month. By integrating the lessons of the past with a forward-looking commitment to equity, the collaboration aims to transform bioethics into a practice that actively dismantles systemic barriers and ensures that innovation serves all communities equally. This partnership underscores the necessity of grounding scientific advancement in the lived experiences of marginalized populations, ensuring that the pursuit of medical progress does not come at the expense of justice or human dignity.
Read the full video transcript
Good afternoon from uh from Boston and
um welcome to those of you in other time
zones and from around the world joining
us this afternoon for our annual
Bioeththics and Black History Month
lecture.
Uh my name is Rebecca Brenell. I have
the privilege of leading the Harvard
Medical School Center for Bioeththics.
And as we get started, I wanted to say
just a little bit about the hi the
history of our black history month
collaboration with the national center
for bioeththics in research and healthc
care at Tuskegee University.
This lecture began um in 2020
uh when we started a relationship uh
between uh under our former directors of
our centers doc Trou at Harvard and Dr.
Ruben Warren at Tuskegee to try to
figure out how bioeththics could uh
develop a dialogue and be a catalyst for
centering the margins and those who had
really not been voices that had not been
included, especially black voices in the
work of bioeththics um in academia and
really to address the ongoing
disparities uh as the height of COVID
19. uh and other social uh challenges.
And uh really what this work became was
an exercise in creating a very deep
between our centers and the people in
those centers. Um and now the legacy of
that collaboration um creating this
trust um through trustworthiness that
doctors Warren and Trou started has
become the legacy that uh Dr. David Hajj
as the dire now the interim director of
the national center at Tuskegee and I as
the director at Harvard have inherited
and so I'm really honored today um for
this year's forum to turn our focus to
black history and bioeththics and the
legacy of the Tuskegee report. I'm
joined today by two esteemed colleagues
for this conversation, professors TS
Harvey and David Austinon Hajj. Let me
begin by introducing them
first. Uh Dr. Hajj. Uh David Hajj senior
currently serves as interim director,
lead ethicist and research professor at
the National Center for Bioeththics in
Research and Healthcare at Tuskegee
University. He previously served as
associate director of education at the
national center beginning in 2017 during
which time he directed the cent's
bioeththics honors program and
bioeththics minor for undergraduates
its annual public health ethics
intensive course and outreach programs
to engage the cent's target audiences.
He teaches bioeththics and public health
ethics courses at Tuskegee.
In addition to his administrative and
academic duties, Dr. Hajj is a
researcher, author, and editor. He is
the editor of the Cent's Journal of
Healthcare Sciences and Humanities, a
peer-reviewed publication in partnership
with the Smithsonian Institutions Office
of Sponsored Programs.
Before his current appointment, Dr. Hajj
served as an adjunct assistant
at Georgia State University and as a
guest lecturer in philosophy, theology,
and ethics at the interdenominational
Theologic Center in Atlanta, Georgia. He
has also held teaching positions in
religion and philosophy at Florida
Memorial University, Nova Southeastern
University, Broward College, Miami Day
College, St. Thomas University, and
Barry University, all in southern
Florida. A native of St. Thomas, US
Virgin Islands, Dr. Dr. Haj's academic
background includes a bachelor of arts
in Bible theology and English from
American Baptist College of Tennessee, a
master of arts degree in education from
Oral Roberts University, a master of
theologic studies degree from the
Canandler School of Theology at Emory
University, a doctor of ministry degree
from Columbia Theologic Seminary in
Atlanta, Georgia, and a PhD in
philosophy from the University of Miami.
Please al um please also welcome uh uh
Professor TS Harvey uh who's an
associate professor of medical and
linguistic anthropology and global
health at Vanderbilt University.
One of the legacies of the Tuskegee
Harvard Bioeththics Collaboration these
last six years has been the deliberate
work to expand our framing and our
community in the work of bioeththics.
And today in welcoming our esteemed
colleague, Professor Harvey to this
conversation, it serves both as an
example of our growing relationships of
and comm community um and community and
our widening lens on the work of
bioeththics itself. And we're so honored
to have him join us in this community.
He is, as I mentioned, associate
professor of medical and linguistic
anthropology and global health at
Vanderbilt University. Dr. Dr. Harvey's
research and interests focus on
expanding scientific partnerships,
developing innovative technologies, and
building local capacity
tackle largecale global public health
and environmental challenges that emerge
at the critical intersection of
vulnerable populations, health
disparities, disease, risk,
environmental degradation, and water
sanitation and infrastructure integrity.
The evolution of this unique
transdisciplinary approach is the
product of more than a decade of funded
collaborative research, capacity
building work, and global engagement
with a broad range of institutions and
organizations including the
Environmental Protection Agency, the
World Health Organization, the Ford
Foundation, and the Robert Wood Johnson
Foundation. And this collaborative work
has been on a wide range of topics but
include but are not implemented to
cross-cultural doctor patient
communication language and culture in
global public health waterbborne
diseases interic illnesses disaster
prevention and relief neighborhood
approaches to risk reduction crisis
management sustainability
and resilience.
uh regarding a really groundbreaking
work that Dr. Harvey has done in
technology. He led the team that created
one of the nation's first virtual
self-sreening tools which helped
individuals assess their risk of being
in uh infected with CO 19 and
facilitated access to health care by
directing users in real time to
resources available in their areas. Most
recently, in his role at the Vanderbilt
Institute for Global Health, Dr. Harvey
developed and designed a lowcost
wearable medical device to increase
prescription prescription drug adherence
globally. Please join me in welcoming
Dr. Harvey and Dr. Hajj.
>> Thank you.
>> Now, really delighted to have you both
with us. To set the stage for our
conversation, we decided in preparing
for our time together today. To
structure our conversation in three
parts, past, present, and future. Uh to
really frame our engagement of the
legacy of the Tuskegee report. Uh to
understand where and to understand where
we're going first to understand where
we've been, where we are now, and what
we see as the opportunities for the
future. And as many challenges as we
have ahead of us, we really want to um
want to think in a forward-looking way
that also brings optimism to the many
challenges uh to the solutions to the
many challenges that we're facing.
So um by way of introduction so we can
all come up to speed quickly uh I got
tasked um with uh providing just a
little bit of history as we get started.
So, uh, when we think about, uh, the
legacy of Tuskegee, what we're really
talking about is that from 1932 to 1972,
over 40 years, nearly 400 uh, sharecro
black sharecroppers in Mon County,
Alabama, were uh were denied treatment
for syphilis and followed and monitored
by physicians employed by the United
States Public Health Service as part of
this study which was not really um uh
had no therapeutic benefit and no uh no
no no aim of providing benefit. It was
really designed to document the natural
history of the disease. The men were
told that they had bad blood literal
quote. Um in fact uh what happened in
the course of looking at the natural
course of untreated syphilis, these men
um uh and the government officials who
participated went to what the final
report of the syphilis
called quote extreme lengths to ensure
that they received no therapy from any
source.
So in 1972,
the New York Times reported that the
Tuskegee syphilis study was quote the
longest non- therapeutic experiment on
human beings in medical history.
following um this um following uh the uh
this publication and the public exposure
of these practices. Um there was a lot
of attention understandably
to um lay out ethical principles for
research with human subjects. And in
1978, after four years of work, a
national commission for of physicians,
lawyers, and scientists released what is
now known as the Belmont Report, which
laid out ethical principles for research
with human subjects.
Um, however, um, and what we're going to
be talking about today is, um, how we
nonetheless have failed to recognize,
uh, um, and, uh, and to make progress,
uh, that has had meaningful impact for
black Americans. Um 18 years after the
publication of the Belmont report, uh
the syphilis study legacy committee in
May of 1996
uh was uh completed really looking at
what the enduring uh enduring legacy um
has been of the US public health service
study. Um and quote uh this report uh
even nearly two decades later after the
Belmont report quote the study continues
to cast a long shadow over the
relationship between African-Americans
and the biomed professions. It is argued
that the study is a significant low
participation of African-Americans in
clinical trials, organ donation efforts,
and routine preventive care. In view of
this, the committee came up with two
specific recommendations. First, what
became a recommended uh public apology
by then President Bill Clinton. um and
also uh the need to address a systemic
way of ensuring that there was a
strategies to redress the damages caused
by this study. And central to the
recommendations of how to do that was
the establishment of what is now the
National Center for Bioeththics in
Research and Healthcare at Tuskegee
University.
So here we are now. Um it's 30 years
after the final report of the syphilis
study legacy commi committee and we know
um uh it's also f um more than five
years after 19 came upon us and we again
experienced major disparities um in
health care that was available um and
the impact of um in that case a global
pandemic disproportion
on black Americans and um and other
Americans um uh of color. And so now now
we turn um in our bioeththics and black
history um
uh conversation today um to really
understand the ongoing leg legacy of the
Tuskegee report, what we need to do and
ought to do to address that um and where
we go in the future.
So I'm going to start um with Dr. Haj um
and um asking you that question sort of
where are we and um what are the
legacies that we see today of the US
public health service study but even
more than that um just to sort of tee
you up you've advocated that we're both
not where and that if we want to go
where we have to be in terms of ensuring
better health for um uh for every
American and in particular for black
Americans um that we need to actually
change our ethics and we need to change
our ethics to uh what you've termed a
distinctly a black bioeththics um and
tell us a little bit about what that
looks like and what it would achieve.
Thank you so much, Becca, and thanks my
dear brother, um, TS Har Jav. And thank
you, family, for being allowing us. I
just want to take just a couple minutes
and run through some slides that will
show us something. In a in a really
recent conversation with Dr. Harvey, we
have one other colleagues. Um, he
mentioned TS Elliott and this very
famous statement by TS Elliott which is
there's always a past in the present.
There's always a past in the present.
Doesn't matter how much one may try to
run away from the past, we're still
living in that experience. This in the
DNA, right? is is part of what we call
ACES, adverse childhood experiences,
where in the DNA, in our structure, in
our experiences, in our trauma, there
exist these particulars that continues
to keep black and brown people where
they are. So, just for a few uh minutes,
I just want to reflect on some of the
present
um categories that continue to resist
what seems to be best efforts. Next
slide, please. First, um, when we talk
about excess deaths, we are talking
about those deaths of black and brown
people, particularly black people, over
and above their white counterparts. Next
slide, please.
Um this one uh when we talk about um uh
the estimated lives lost or years of
lives lost given blacks against their
white counterparts. It adds up to about
80 million li um years of life that has
been lost.
1.63 63 million lives lost per their
group between 1999 and 2020. These lives
are these are years that will never be
gotten back. And this creates a gap in
the conversation. Not a abstract gap,
not an abstract gap, but a preventable
gap. Next, it's something that but that
that that that that promotes or allows
for funerals because black people just
keep dying at a at a faster rate. Um
next, black and brown black um uh the
life expectancy that's okay. maternal
mortality. The life expectancy um the
maternal mortality rate shows that black
women are 3.5 times more likely to die
in childbirth than their white
counterparts. Next one which is infant
mal mortality
in infants are twice as likely to die
than their white counterparts.
Next slide please.
And all in all or in terms of all lives,
we are black look at look at this the
the levels here. Black and brown people
well particularly black in this one is
still leading in the kinds of deaths
that are preventable. All right, let's
take that down. Please take the slide
all together.
That's all I wanted to say. I just want
to demonstrate evidence base that there
is a situation that continues long after
the the syphilis study that continues to
to demonstrate a lack of attention to
black lives and black lived experiences.
So um when we when uh to the question
Becker about you know how can where are
we first thing we got to admit that
there's something deeply and profoundly
wrong. You mentioned CO 19 a moment ago
and we must ask the question how did CO
19 find black people at a higher rate
than they found any other people?
How did how did co 19 know to go to
Albany, Georgia and say, "Well, I'm
going to take I'm going to I'm going to
take the lives of these black and brown
people at a faster rate than other
people." How did it know? Well, one of
the ways that it knows it to do this is
because of um co-orbidities because of
those excess death categories that I
just mentioned, namely cardiovascular
disease, hypo hypertensive, cancer, HIV,
etc. um preventable deaths, right?
violence and gun violence because of
those excess deaths categories. It makes
creates a vulnerability for black people
and brown people in such a way that
whenever something like a co 19
catastrophe hits
that co-orbidity become like a
trorbidity right you already have
diabetes and hypertension and now
something else on top of it take you
out. So, I will just pause right there
um and just that those are the
kinds of things if we do not give
attention to to uh black lives and brown
lives and lives that are vulnerable in
public health, then we will see these
kind of vulnerabilities act out in very
traumatic ways down the line.
>> Okay. Thank you so much. That was um an
incredibly important framing. I'm going
to come back to uh what you um come back
to Belmont and black bioeththics in a in
a minute. I'm going to give um Professor
Harvey an opportunity to respond to um
what you've said um and just to tee it
up by saying that um you've also from
the perspective of uh what you of uh
incidental anthropology Dr. Harvey um
really talked about the same kind of
intersectionality referring um this
Gordian knot of racism. Little did I
know when we first met and I talked
about the problem as a Gordian not that
I was in fact um quite superficial in my
analysis of the situation and that you
have g given this really substantial
thought looking at the structural
institutional and global factors that
have really continued to um affect black
lives to this to this day. So I'll give
it to you Dr. Dr. Harvey for your first
comment.
Thank you so much uh for teeing this up
and thank you uh for the opportunity um
Dr. Hajj uh to be invited to the
conversation. Uh so I would like to sort
of echo some of the things that u Dr.
Hodgej said but to frame this in terms
of thinking about uh the gaps and return
to a conversation about the gaps. So
often times when we think about the the
Belmont report which is sort of a global
northern standard because as we know uh
the Belmont exist in the shadow of
Nuremberg. Uh when we think about that
we think about a kind of strict
constructionist view of that which has
really been a concern with as it was
written uh bioeththics as it relates to
research with human subjects. But as uh
Dr. Hajj points out part of the the
short-sightedness of that uh is to look
at the downstream implications of
something like the Belmont report and
its circumscribed uh limitations and
preoccupations with what constitutes
research with human subjects and
understanding the intersection between
research with human subjects for example
and clinical trials. research with human
subjects and for example bioreositories
research with human subjects and for
example um public health and so this
brings us to a rather perplexing problem
and you can think about it in many ways
uh from the field of the arts and
humanities you could frame it as the
Gordian knot of course a reference to
Alexander for those of you who've heard
about the story of the Gordian knot the
idea is that you have this tangled mess
um that cannot be untangled people have
written classical pieces of music about
it. Henry Pcel wrote a piece on the
Gordian knot. But the idea is it's a a a
complex problem um that can't quite be
untangled. And as the story goes, uh if
you could come to this town and untangle
this mythical knot, which you can think
uh metaphorically relates to uh health
disparities, health inequality, uh if
you could manage to untangle that,
right, somehow you'd be ruler. And this
of course is connected to the myth of
Alexander the Great. And the idea was
that he came in and he didn't attempt uh
to unravel it. He just cut it. But in
public health terms uh they don't talk
about Gordian not they talk about wicked
problems. And the idea here is a similar
thing in and a problem in which you know
it's so very difficult to define uh
various pieces reaching in and out of
it. And oftentimes what you hear is that
it's complicated. Uh but one of the
things that we say uh in our research
team is that to say that something is
complicated is not an answer. It is a
description. And so what we hope to do
is is to build beyond, right? and to
think about as we reimagine uh Belmont
uh under the the framework of a Tuskegee
report report reimagine the
possibilities to think about the
complexity of the problems as human
problems that have human solutions. So
I'll I'll stop there. Thank you for the
thank you for the question.
>> Um that that's great. So two two two
perspectives on this, right? looking at
the continuing um the continuing gap and
the continuing
um the continuing state of where we are
when we look at public health and the
lives of black and brown people, but
also and the global north, right? But
but also um looking at this notion that
we can't things complicated. Um it's it
that that's not going to in and of
itself help us find the answer, right?
it just it ought to push us further to
finding to finding answers and
generating uh approaches and solutions.
So um you uh Dr. Harvey, you set us up
really well in talking with about some
of the limitations of the Belmont report
and how really um it focused us in ways
um that um were strictly applied to
bioeththics and research on human
subjects in in particular ways. And Dr.
you in uh your work have talked about
that as well about how the principalist
ideas in the Belmont report um aren't
really what we need right now that we
need a different kind of bioeththics. Do
you want to tell us about why that is
and about your conception of um uh of
black bioeththics and what that means
and how it would help us not just
describe a problem but actually generate
solutions.
>> Thank you very much. and please call me
David. Mama named me David and I like
hearing David.
David means beloved so I like hearing
it. Um and thank you TS because that
really does a great job in taking me to
how to define black bioeththics. Um uh
there's there's
there's always a discomfort in lending
and add giving these adjectives to
things. Um because one would always ask
like why is black but why I call it
black bioeththics and how is that is
that a is that a pigmentation thing and
I've always not thought of it as a
pigmentation thing. I've always looked
at it as a protest thing. the way in
which uh blackness came about in the
understanding of blackness or what some
understandings of blackness meant
through the 60s that brought about black
theology for example with James Cole and
JD Otis Roberts in the 60s and the 70s
as a way of thinking about how to deal
with the exclusion of black people in
the field of theology and thus the field
the field of sociology and the social
sciences. Right? How do you how do we
make it known that liberation theology
it should be an important factor in how
black people think about things and this
was done interestingly in partnership
with the with the um lat the Latin
American theologians Gustavo Gutierrez
and a host of them Sagundo and such so
now so so my taking back of the term
black from black theology is how I'm
using it because it encourages and it
motivates and it in is in it's inclusive
rather than exclusive. It says that I am
just as interested in uh as a black
bioethsist. I'm just as interested in
the the our Native American populations.
I'm just as interested in um Alaskan or
AsianPacific uh populations. I'm just as
interested in my in my Hispanic brothers
down at the border, the um the Mexican
brothers and sisters or the the the the
Cuban brothers and sisters or any such
thing as I'm interested in those in the
Appalachian Mountains, right? Those who
are poor because quite frankly when
we're talking about ethics and when we
talk about principles, we are talking
about the least, the lost and the left
are. We're talking about people who are
vulnerable and they cannot fight for
themselves. And that's why blackness is
so important because blackness then
becomes a metaphor for what it means to
not be able to fight for oneself without
some advocacy from others. So black
bioeththics is not simply about
pigmentation. That would be
reductionist. It's about identification.
How do you identify with people who are
the least of also nerfed out? Because
populations that was what public health
is about populations but bioeththics is
about individuals. And if those two are
not conversational then we miss
something extremely important. It is not
sufficient to speak only in terms of
public health and populations because
populations are made up of individuals
and individuals are made up of all kinds
including least lost and left out poor
people brown people um Latinos um capac
cap capacinos the whole the whole gamut.
So that's what black bioeththics is and
and and just to touch on something that
you said in your questioning uh Becca
with respect to like how does this jbe
with the Belmont report we are not in
any way interested in the rejection of
the Belmont report. The Belmont report
has done and continues to do what it was
designed to do. It was a research for a
research formula to ensure that certain
protections were in place. We ask the
questions protection for whom?
We ask the questions. We ask the
question that mainstream bioeththics may
not may not be asking. And that's why
again black bias ethics. So the Tuskegee
report is less interested for example on
just justice is interested in social
justice. Correct. See we're not when we
talk about respect for person, we're
talking about agency more than we're
talking about autonomy. When we're
talking about um um beneficence, we're
um the movement from benevolence to
beneficence have already been
established. But we are saying unless
there's another step that is the notion
of empathy and care to ensure that
beneficence take on real value for the
least of those that are left out, then
we're still rhetoric, right? We're still
rapping. We're not really engaging.
>> Thanks. That's um that's incredibly um
clear and helpful and that what we're
talking about um and one of the legacies
of the Tuskegee report then is really
how we continue to center the margins in
very important ways both around public
health but individual health um as well.
Um
uh Dr. Dr. Harvey, I'm you know I I um
so I should say I think it's obvious to
everybody the affection I've had for a
long time for you. Um Dave, Dr. David
Hodgej and um my my new colleague Dr. TS
Harvey. Um I'm being formal only so that
I don't slip um and forget that we have
hundreds of people in attendance
watching this and that this is going to
be on the internet. um and we hope
hundreds and thousands more join us in
this critically important conversation.
So, it's out of the utmost of um respect
and and um affection that I'm I'm so
formal to make sure I can put forward
this work in the most important. Um so,
with that being said, um uh uh Dr.
Harvey, when you think about this in a
global context, um you've you've also
brought other pieces, right? um not just
from individual populations and
individual lives but the environmental
the structural the institutional uh
factors that really affect uh
disparities um not just in health but uh
disparities in life because as Dr. Hajj
has showed us uh if you one begins life
with a foreshortened expectation of what
that's going to be um it it very much
affects um the the conditions and one's
circumstances from the very beginning.
So, I'll let you um uh uh tell us a
little bit about how you've approached
um this inheritance, this legacy um and
how what directions um you see that we
need to go.
>> Yes, absolutely.
And so my my colleague uh on our current
Robert Wood Johnson Foundation grant is
uh Ted Fischer who's not with us today.
But part of that grant uh is under the
the the unit that essentially looks at
global solutions for US problems. And
what we wanted to do as we thought about
the challenges and opportunities in
bioeththics is not to limit that
discussion to examples of what we know
has happened in the US historically.
Uh and not also to just look abroad for
other examples of atrocities, but to
recognize that these challenges are
shared and to look beyond our borders.
um to think through the ways in which uh
perhaps other populations,
other universities, other researchers
have grappled with similar problems. To
think through the ways in which for
example you can reimagine bioeththics
around uh research with human subjects a
way that brings vulnerable populations
the populations that uh my colleague Dr.
Hajj mentions the least the lost the
left behind. How do you bring them uh to
the discussion? But not at the end, not
as an add-on or a footnote, but how do
you bring them in to reimagine what
bioeththics could be, right? And in
order to do that, of course, you have to
get out of the the sort of framework and
the shadow of of Belmont and also out of
the the sort of the western hubris that
somehow we're the only the only ones who
has who have a notion of of ethics,
right? Which is why I think my my
colleagues uh framing of this under the
opaces of care ethics allows us to think
about that in a broader context and to
allow those other models indigenous
models for example to inform uh the ways
we think about for example consent. The
ways we think about what constitutes the
community, how long consent is good for,
the ways in which we think about
autonomy, who has autonomy, what does
autonomy presuppose, uh notions of
justice, uh to the degree to which uh
benefits versus uh risk. All of these
things can be can benefit from a framing
and a thinking about this in a way that
engages impacted communities to rethink
uh from construction up the way we
reimagined uh we reimagined what
bioeththics could be under this uh
Tuskegee report that we're that we're
building.
>> So um so many pieces um to what you've
just said. Let me see if I can highlight
some of the the salient features to move
us ahead, but a bioeththics that moves
not from the top down and from um from
abstract ideas and principles, but a
bioeththic that's embodied and informed
by the voices and the lived experience
of those um who would be affected um
either by existing challenges um or by
future interventions. And also this
notion of uh what it means to respect
dignity and be an autonomous agent is
one that must be framed in the context
of care and community and relationality
and not in thinking about um individuals
um as isolated um isolated or um um
uh isolated or separated from the
context, the people, the relationships
and the circumstances in which um we
found ourselves. Um and that if we
really reimagined that what we'd be
looking at or the big um the big change
would be not to start with uh our own
limited answer western answers right to
glo to global challenges but rather to
open up our minds and open up uh not
just our minds though our hearts as well
uh to be engaging these problems from
the perspectives of those uh those whose
voices have um uh been uh either not
heard um or even si actively silenced.
So uh critical critical um things to
think about and when we think about the
fact that 60% of the world's population
um lives in a lower middle inome
country, right? to think about a
bioeththics that comes from um comes
from these um highinccome
centralized or abstract notions. Um we
begin to see really how much of a
mismatch that is. So I want to turn to
um so many more questions I can ask and
I'm also mindful that I have you both
only for a short period of time. But I'm
particularly um want to invite you Dr.
Harvey to talk to us a little bit about
um how that how you've um bridged um the
use of technology and some of these
innovations to um to begin with uh with
the um in the community. uh to begin
with the lives and the stories of
individuals uh to address problems on uh
an individual on a public health scale
as opposed to from the top down. Um we I
mentioned in your introduction about um
the uh innovation um to locate treatment
for COVID 19. Uh we talked about a
wearable device. How do you what are um
how do you see that intersection as
bringing us forward in making um in
imagining uh a new bioeththics and new
commitment to the lives of persons.
>> Yeah, thanks for the question and I just
want to sort of um you know pivot back
to Dr. Haj's comments in terms of of
where we start right so how we approach
these problems whether we call them
wicked problems or Gordian knot right if
we approach them uh from impacted
communities then the way we design and
imagine uh interventions and who we
imagine and design those interventions
with with uh gets defined by where we
start right and so understanding the
problem and uh Dr. Dr. Haj has done a
lot of work in this at the National
Institute for Bioeththics and
Healthcare. Sort of understanding the
problem sort of not setting out for
example to
answer the problem that you
hope is the central issue, right? And
and sort of uh engaging with
interlocutors and communities to
understand those perspectives. Uh
specifically in the area of of research
with human subjects. uh we can think
about um organ transplantation, we can
think about uh all sorts of spaces that
are informed by engaging directly with
those communities. And so that kind of
interdisciplinary
um approach uh which I think is grounded
in anthropology which is an
interdisciplinary uh social science sort
of lends this ability to think um not
just horizontally but also to think
about the ways in which one needs to
connect these sort of propositions and
abstract ideas of principles and
guidelines which exist sort of if you
will metaphorically in the penthouse.
house that those ideas have to travel to
the basement to the ground uh and it has
to be informed in in some cases right by
what's happening on the ground and and
otherwise again we are essentially
solving problems that are not actually
there and and so what I've sought to do
in many aspects of the work is to build
collaborations transdisciplinary
collaborations uh around the problem to
bring people to the table that have
disperate expertise, right, to dismantle
the silos that get in the way of of of
working together on these sorts of
problems. Uh something that my colleague
has done consistently in terms of the
ways in which he thinks through these
problems and and frames them.
Um, so, um,
maybe this could be to either one of
you, but, um, what, um, I of course
jumped to the solutions immediately or
what we need to do about it, but you're
reminding me that I, um, I wanted to get
out of the hot seat of thinking about
the history too quickly because actually
what we need to be doing even especially
now in the present before looking
defining not just redefining the the
problems but also redefining the way um
in which we uh we identify um uh
identify the problems that we want to
address. So that's very very helpful. I
feel like my wings are a tiny little bit
clipped um and in a very good way. I
feel that's a very um a really
transformative way of thinking about
this. Um so as usual having the
privilege of being here I've learn I've
um clearly already learned more than
I've been able to contribute. Dr. Hajj
what would you say to us about that? So
when we think about this through the
lens of um of the least the lost and the
the left behind. Um how does that change
the way we frame um what we need to be
focused on and uh and how we do our
work?
>> Thank you so much. Um, I was thinking as
TS was speaking about a couple of years
ago, I was invited to a to a
conversation at U MIT and I learned
something new. U I I just recently
learned this chat GPT thing, right? That
was fascinating to me. And then I
learned um so there they asked question,
do you know how this works? And so asked
around the table and we all came up with
something and we were all wrong. And he
said um um AI technology especially chat
PT etc works by anticipating the next
word.
I didn't know that. So now immediately
my question is whose next word like
where did you get that next word from?
Because if I'm not in the conversation
I'm from the Virgin Islands. My next
word would be something like what wrong
with ar man right that's my next word
right what and yours might be what's
wrong with you you know what's wrong
with y'all so there is a there is a um a
a misstep
when if we do not understand or start to
work with the power if of implicit bias
and biases in innovation and in
technology we will continue to go down
the road of excising those communities
that need to be involved.
How at what point did grandma's voice
become the next word? You know, when was
her voice included in this technological
thing? Um I I uh one of the one of the
things that um that we're doing in our
research with our family at Vanderbilt
is we are looking at how in technology
how exclusion occurs not by racism
but by comfort zones.
I had opportunity to work with some
brilliant, brilliant folk at uh Case
Western who developed some brilliant
brilliant technology
and in terms of prosthetics and and um
the person who would who uh was the
clinical trial recipient
was a white guy, very nice guy. I I
really enjoyed with we cried a lot. We
we shed a lot of tears thinking about
how he lost his arm and how that
technology gave him a opportunity to
feel his wife and his children's
physical hand again. Very emotional.
Well, see, my brother also lost his arm
in a motorcycle accident. So, my
question was why wasn't my brother
included in the clinical trials? And so,
it was not that they that black and
brown people were excluded. is just that
what was closer it had to do with
proximity. That's why care ethics is so
important because it's relational. Has
to do with proximity, right? If you have
a relationship with someone next door,
someone down the street, you will say,
"Oh, you know, um Haj, his brother, he's
he lost his arm." And so therefore, when
we're talking about clinical trials,
we're talking about um what clin one of
clinical trials and and black
bioeththics and Tuskegee report. We're
talking about making the invisible
visible. How do we lift the veil as
which is very symbolic of Tuskegee
coming to Tuskegee Gate and there's a
there's a book Washington lifting the
veil of a former slave. How do you lift
the veil? How do you make it such that
people who are unseen can be seen? I'll
give one way and then I move on. Um and
that is one way to do it is that
find ways to include family members in
the conversation of clinical trials
before they get to the deathbed.
My predecessor and my mentor and my my
brilliant colleague Dr. Ruben Warren um
he was he he taught me so much along
these lines. when we doing clinical
trials and we wait until a person is in
their deathbed and offer them a informed
consent document that reads like a PhD
dissertation and say sign this what are
they going to do so therefore if we so
therefore to get to the least of loss of
e out left out and we're if we're going
to deal fairly ethically and caringly
with communities in engaging with
communities then we need to be serious
and we need to be authentic authentic
and we do not wait until a person has is
out of choices to say here's a choice.
>> Okay. So, um so many um so so much
there. Um Dr. Harvey, how do how do we
do that? How do we create choices? How
do we bring in lives and voices that
matter? um before uh we're um uh at the
time that we're thinking about our
innovations,
our possibilities and not when uh we're
looking for last stitch efforts as Dr.
Hajj has so eloquently laid out.
>> Yeah, that's a that's a good question. I
think um just to go back to a a point
that was made earlier, there's a
recognition
that technology for all of its
capabilities
uh whether or not we're talking about
artificial intelligence, large language
models, or um uh really sophisticated uh
prosthetics, uh technology is not
neutral.
Um and and I think one of the things
that needs to sort of be acknowledged is
that um it's not neutral in many cases
uh it replicates existing structures,
existing uh notions. And so when when
Dr. Hodgej talks about the veil, uh one
of the things I think about is to mark
the unmarked category. And so to think
about uh prosthetics and to look at the
for example uh who the intended
recipients are, right? And so for many
many years um prosthetics
disproportionately went to veterans
because of all of the wars. But now we
realize uh you know um that many of the
amputations now are associated with um
diabetes.
And so how do we reimagine who the
recipients are? How do we reimagine
deservingness? Right? And so this has to
be more than uh something that we add
on. Uh Dr. Haj likes to joke about
someone who once said who will not be
named here said put a little ethics on
it, right? Put a little bioeththics on
it. And so the idea here is that this is
not something that we add on. This is
something that we rethink. So we
rethink, right? So for example, people
say, "Oh, oh well why black
bioeththics?" Right? as if the Belmont
Report in and of itself is like a
version of McDonald's. You know,
McDonald's is ethnic food. The Belmont
Report is marked. And so part of what
you have to do is to think about how the
unmarked
um sort of prefigures a certain set of
expectations about deserving. And so as
we go uh back and as we move out, we
think about health disparities and who
you know who who who are the the the
populations that are impacted now and
then reimagine those technologies and
reimagine those interventions by
understanding those challenges. But to
do that, we have to move beyond
utilitarian ethics to what Dr. David
Hodgej talks about as fundamentally
relational. Right? And this has been
thought about in many many different
ways. Uh the philosopher Levvenos talks
about an encounter with a face, right?
And and and sort of what he suggests is
that the first thing that one must do
when one encounters a face, this is
Emanuel Levenos, is that there's
recognition, right? Recognition has to
come first. Recognition becomes before
relationality. So we can use many many
different philosophical frames to think
this through. But we need to again um
recognize that technology is there as an
aid and can be used in many many ways
right but also understand the kinds of
disparities that some of these
technologies reproduce as Dr. Hajj
mentioned I mean when you thinking about
large language models uh who were these
models trained on when you think about
soft AI for example in something like
Microsoft Word and the editing out for
example of uh the ways in which people
hedge right it edits that out so that
the voice sounds more masculine uh which
is a projection of authority now I'm a
linguist as well and and what does that
look like when a woman is using for
example um Microsoft Word and is editing
out uh the the kinds of phrases that
allows one to position oneself as less
than an authority and then that gets
sent out and of course uh in the the
context of depending on who sends it
right it then gets read as someone who
is for example uh overly controlling or
someone who is overconfident. So
technology is not neutral right and so
rethinking the way in which we approach
it the way in which we use it you know
that the the response is not to kind of
cast it aside is to to reimagine it
understanding uh its complexity
understanding the possibilities as well
as the limitations.
Can I add something that that you just
you just peaked my brain because this
embedded in in the in the models and
embedded in what you said over Microsoft
Word or soft models is then the a chance
for mis misogyny to to to prevail. And
if misogyny can prevail and other kinds
of discriminatory practices can prevail,
then you know what else is being um
prevalent in conversations and and our
young people then have to use this kind
of technology and they they they do not
they may not realize to what extent
things are bought into ahead of them or
what kind of ethics are embedded are
being shared. One of uh TS just
mentioned this uh uh reimagining how
prosthetics are used and for whom and
one of the things that is just so
interesting to me is that the technology
to to get that done TS is going to
require a lot a lot of money right a
lots of lots of money
it's in the hands the money is in the
hands of gamers the technology is in the
hand of gamers so there has to now the
partnership with gaming communities,
right, and gaming companies to see to
what extent that partnership could bring
about some kind of health care for those
persons who really need it. Because
again when we excuse me um remember in
every state in the country blacks lead
in either excess deaths or um the
population lead in disparities in every
state in the country. So if that is the
if that is in fact the case then there's
one could one could could determine from
that that uh that um a large portion of
those who have amputations are black and
brown people. Right? The same thing is
true with kidneys. A large portion of
who those who need kidney transplants
right now are overarchingly black
people. So then who gets that that that
transplant and how does that work and
how do you pay for it? Because a a
porcene transplant or a pig kidney into
a human which may have the life
expectancy of about 5 years and it cost
$150,000 to do then how does that work
when there's a kind of financial
bankrupt in the health care system. So
back to the goian knot, right? So now
you take something complex and you make
it even more and more complex and unless
and we go back to our ethics while a
particular brand of ethics undergurs
this and mitigates some of this other
stuff because it says that relationships
matters. Caring about people ma matters
and is driven by empathy. Empathy is a
capacity to understand what somebody
else is going through. Caring is how you
respond to that. Compassion is how you
respond to that, you see. Okay, that's
>> all right. So, I'm going to bring this
sort of back to um uh to a few responses
to that one. Um uh Professor Harvey when
you said that, you know, technology is
not neutral. It replicates existing
structures. I would take that even a
little bit further to say that that um
that not only does it replicate existing
structures that it can actually um
magnify and amplify the disparities that
occur as a result of the existing
structures. And that really if we if we
take this notion seriously of centering
the margins um we would get out of the
um get out of thinking about health as
the kind just the kind of health care
that we deliver um and really embrace
what Dr. Haj is talking about here. Um,
and think about some of the models of
health community health interventions um
that have been very effective um in
communities in particular in um the
global south at beginning not with the
high level professionals but even
showing um incredibly powerful results
around health and mental health, right?
With community health workers, right? or
um um and not overly um beginning with
our connectedness and our relationships
with each other rather than with um the
biggest science or the highest training
or technical knowledge that we have.
Right? So really embracing this notion
of care, relationality
um rec
um and empathy um as first as a
precursor to anything that we would do
whether it be our technology. As we seek
to use this technology towards a
positive future that would close these
health gaps and and um beyond closing
the gaps, advance the health of those
who have been left behind. in
particular. So, we're down to our last
few minutes already. Um, I've asked
about um one of a hundred questions that
uh that we could talk about that I had
hoped we'd engaged today. So, I hope we
can do this again. Um, we've had a lot
of questions both before from um from
attendees and coming in throughout the
um our time together and one really
sticks with me. And so the question um
uh question comes from um a young person
thinking about a future career, one that
embraces bioeththics and committed uh to
advancing health um in um clinical
trials and other interventions. What do
we tell our young people? What would
success look like? And uh how do we tell
our young people or help um help inspire
them about starting in a place so that
in another generation and a half after
this conversation, we're not still in
the place that we are now um 30 years
after uh the commission report.
Anyone can go first or second. Um
lightning round answer to another um if
not a wicked problem, a wicked a wicked
Gordian question.
Okay, I'll go I'll go first and make
I'll make it quick. There's something
Becky, you've heard me say time and time
again, and my dear brother Lan Forro,
who I'm sure is listening in, that
there's right now a 13-year-old girl in
Kenya or in Ukraine or in Guatemala or
in Tuskegee or a 30-y old girl anywhere
whom I do not know, but she's my sister.
And I have to keep keep this girl or
this boy, it's a metaphor, right? I have
to keep this person at my right at the
beginning of my head each and every day
that I cannot take time off um beyond
what's reasonable, right? But I can't
just stop thinking about them because
the time is going to come when something
I do here would affect where they are
there and I must continue to push and so
therefore young people are thinking
about this kind of work that is public
health ethics and public health and
bioeththics neuroeththics etc. It is
important to engage and is it's not is
sometimes you're working in the dock by
yourself but other times we're working
in a community like we are right now.
>> Well, I think we we certainly do our
best work in community, right? And so
that that's one thing that I think can
can inspire uh inspire young people to
begin to um to talk about relationships
but to build them. And I think that
that's what been one of the legacies of
our work together over the last six
years um is making sure that we don't do
this work in isolation and as silos, but
that we build and change the nature and
the scope and the possibilities of our
relationships um for which I will um
forever be indebted to to you and Dr.
Rubin as our um as our partners in. Um
Professor Harvey, we give you the final
words of encouragement and wisdom.
>> Yeah. So I guess I I would just echo
what's been said, but I'm thinking about
Antonio Grochi's um
uh pessimism of the intellect, right?
And how the optimis the optimism of the
will is stronger than the pessimism of
the intellect. And I would say, you
know, as we are teaching students about
these problems, the thing that we don't
want to do, right, is to presuppose that
just because previous generations didn't
solve something that there isn't a
solution. We have to set aside our own
hubris and our own understanding of the
problems and open up the possibility
that that anyone sitting in the
audience, any student that they are just
as likely to have a solution to
something that is or would be
intractable problem as the next person
and to engage that seriously, right? And
to not sort of strap people with the
burdens of the past. understand those be
but be willing to and able to and
encourage them to and to create an
environment in which people can imagine
alternative futures.
>> Um thank you so much. I think that that
really captures um optimism of the will
um and really inspires um our younger
generation not to be limited by um by
not to be limited by the past but rather
informed by the past to imagine and
create a better future. I thank both of
you for joining me um this evening um
for continuing to celebrate
our rel
uh and the things that bind us rather
than divide us. Um, and I'll look
forward to our continued conversation
and the next iteration of this
partnership um, next February for our
Black History Month celebration uh,
between uh, the Center for Bioeththics
at Harvard Medical School and our dear
partners and family at the National
Center for Bioeththics and Research and
Healthcare at Tuskegee University.
Thanks so much, Professor Harvey,
Professor Hajj, um, and to all of you
for joining in this critically important
conversation. Take care. Bye-bye.